Video | 15 February 2020 The Big Pharma double dip explained 1 min RESEARCH AND DEVELOPMENT Did you know that Big Pharma is making us pay twice for many of the medicines we buy? In this video we break down the numbers. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicIssue briefLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Statement | 16 October 2014 Research and development Vaccines MSF responds to GSK remarks on Ebola vaccine Opinion article | 02 October 2014 Research and development Why We Need Open Source Pharma 4 min Statement | 22 May 2014 Research and development MSF intervention on the report of the CEWG on R&D at 67th WHA Statement | 31 January 2014 Research and development MSF responds to news of pull out of neglected disease R&D by AstraZeneca 2 min Statement | 24 January 2014 Research and development MSF intervention on CEWG R&D financing at WHO 134th Executive Board meeting Statement | 24 January 2014 Antimicrobial resistance Research and development MSF intervention on antimicrobial resistance at WHO 134th Executive Board meeting Statement | 23 January 2014 Intellectual property and trade Research and development South Africa MSF intervention on access to medicines at WHO 134th Executive Board meeting Statement | 11 December 2013 Research and development MSF responds to G-FINDER survey on R&D funding for neglected diseases Load More
Statement | 16 October 2014 Research and development Vaccines MSF responds to GSK remarks on Ebola vaccine
Statement | 22 May 2014 Research and development MSF intervention on the report of the CEWG on R&D at 67th WHA
Statement | 31 January 2014 Research and development MSF responds to news of pull out of neglected disease R&D by AstraZeneca 2 min
Statement | 24 January 2014 Research and development MSF intervention on CEWG R&D financing at WHO 134th Executive Board meeting
Statement | 24 January 2014 Antimicrobial resistance Research and development MSF intervention on antimicrobial resistance at WHO 134th Executive Board meeting
Statement | 23 January 2014 Intellectual property and trade Research and development South Africa MSF intervention on access to medicines at WHO 134th Executive Board meeting
Statement | 11 December 2013 Research and development MSF responds to G-FINDER survey on R&D funding for neglected diseases
